Market Outlook
By 2035, the U.S. Single-Use Gastroenterology Devices Market is expected to reach approximately USD 7.15 billion, expanding at a CAGR of 9.67% during the forecast period 2026–2035. This report estimates the market at USD 2.84 billion in 2025, with historical analysis covering 2021–2024. Values throughout the report are expressed in USD billions.
The historical market expanded from approximately USD 1.90 billion in 2021 to USD 2.58 billion in 2024, before reaching USD 2.84 billion in 2025. The progression reflects a structural shift in U.S. gastroenterology from reusable procedural accessories toward pre-sterile, ready-to-use devices that reduce reprocessing requirements, simplify inventory control, improve procedure-room readiness, and mitigate contamination risk. The transition is occurring across routine colonoscopy as well as higher-value procedures such as ERCP, endoscopic ultrasound, endoscopic mucosal resection, endoscopic submucosal dissection, GI bleeding management, stricture dilation, enteral access, and advanced tissue acquisition.
For purposes of this report, the U.S. Single-Use Gastroenterology Devices Market covers disposable gastrointestinal endoscopes and single-use devices used primarily in gastrointestinal endoscopic diagnosis and therapy. Major product groups include biopsy forceps, cytology devices, polypectomy snares, injection needles, endoscopic clips, retrieval devices, guidewires, sphincterotomes, dilation balloons, EUS needles, ERCP accessories, enteral-access kits, selected drainage devices, disposable endoscope attachments, and fully disposable gastrointestinal endoscopes. Reusable endoscopes, visualization processors, imaging towers, automated endoscope reprocessors, general surgical capital equipment, and reusable accessories are excluded from the core market estimate.
The U.S. is particularly attractive for single-use gastroenterology manufacturers because procedure volumes are exceptionally high. More than 22 million GI endoscopic procedures were estimated to be performed in the country in 2019, including approximately 13.8 million colonoscopies and 7.5 million upper endoscopies. Even modest growth in procedures generates substantial recurring device demand because many procedures consume multiple disposable products during one episode of care.
Clinical need is equally important. Digestive diseases affect an estimated 60–70 million Americans, while colorectal cancer remains one of the largest cancer burdens in the country. Approximately 154,270 new colorectal cancer cases were expected in the U.S. in 2025. Screening expansion is also creating a long runway for procedural demand. Only about two-thirds of eligible adults were up to date with recommended colorectal cancer screening in recent national data, leaving a substantial population that has either never been screened or remains overdue.
The commercial opportunity extends beyond procedural volume. Single-use products increasingly compete on total workflow economics. U.S. endoscopy departments are evaluating products according to case turnover, nurse preparation time, sterilization and reprocessing requirements, device availability, procedure reliability, supply-chain complexity, contamination risk, and the cost of repeat procedures. This procurement environment is particularly favorable to manufacturers that can offer comprehensive disposable portfolios rather than isolated accessories.
The modeled market trajectory implies approximately USD 3.11 billion in 2026, USD 4.51 billion by 2030, USD 5.94 billion by 2033, and USD 7.15 billion by 2035. Growth is expected to be strongest in disposable gastrointestinal endoscopes, advanced therapeutic endoscopy accessories, defect-closure products, EUS tissue-acquisition devices, ERCP consumables, and workflow-oriented products that consolidate multiple procedural steps.
Introduction
According to the U.S. Single-Use Gastroenterology Devices Market Report, gastroenterology represents one of the most consumable-intensive procedural specialties in American healthcare. A routine colonoscopy may require a snare, biopsy forceps, retrieval device, injection needle, distal attachment, polyp trap, hemostatic clip, or several of these devices depending on findings. Advanced procedures can consume substantially more products. ERCP cases may require guidewires, sphincterotomes, extraction balloons, dilation devices, baskets, cytology tools, stents, and drainage accessories, while EUS procedures require specialized tissue-acquisition needles and therapeutic accessories.
This recurring consumption model differentiates the market from capital-intensive endoscopy equipment. Hospitals generally replace imaging processors and reusable scopes over multi-year cycles, whereas single-use devices generate revenue every time a procedure is performed. As a result, procedural volume, physician preference, formulary placement, vendor contracting, and clinical protocol standardization exert a direct influence on annual market demand.
The broader U.S. delivery infrastructure provides a strong foundation. The country has approximately 6,100 hospitals, more than 907,000 staffed hospital beds, and a large ambulatory surgical infrastructure. Medicare-certified ambulatory surgery centers exceeded 6,100 facilities by 2022, and gastrointestinal endoscopy represents an important procedural category within the outpatient care model. Migration of appropriate endoscopic procedures away from inpatient environments strengthens demand for devices that are pre-sterile, easy to inventory, require minimal setup, and allow small centers to operate without extensive reprocessing infrastructure.
The economics of the ASC environment are especially important. Independent and physician-aligned endoscopy centers operate with tighter staffing models and greater sensitivity to room turnover than major academic hospitals. A device that saves only several minutes of preparation, reduces reprocessing dependencies, or eliminates an instrument exchange can generate meaningful operational value when multiplied across thousands of annual procedures.
The market is therefore moving away from a simple disposable-versus-reusable debate. Procurement teams increasingly examine whether a device can lower the total operating cost of a procedure. In certain high-volume routine applications, reusable products may remain economical. In other applications, particularly where contamination risk, procedural variability, emergency availability, device degradation, or specialized reprocessing requirements are important, single-use products can provide a stronger economic case.
From 2026 through 2035, growth will be increasingly determined by therapeutic complexity. Conventional biopsy and polypectomy will remain the recurring-volume foundation of the market, but higher-value expansion will come from advanced resection, defect closure, EUS-guided diagnosis, pancreaticobiliary intervention, disposable endoscopy platforms, and single-use devices designed around new third-space and incisionless procedures.
Key Market Drivers: What’s Fueling the U.S. Single-Use Gastroenterology Devices Market Boom?
The first major driver is the enormous procedural base of U.S. gastrointestinal endoscopy. Colonoscopy alone accounts for well over half of major GI endoscopic procedure volume, creating consistent consumption of snares, biopsy forceps, retrieval devices, injection needles, clips, distal attachments, and specimen-management products. Upper GI endoscopy adds another substantial recurring pool of procedures requiring tissue-acquisition, dilation, hemostasis, foreign-body retrieval, and therapeutic devices.
The second driver is colorectal cancer screening. U.S. screening recommendations now begin at age 45 for average-risk adults, materially enlarging the eligible population compared with historical screening beginning at age 50. Recent national data show that colorectal screening participation remains well below complete population coverage, particularly among adults aged 45–49. This creates a durable procedural opportunity rather than a short-term screening surge. Every incremental colonoscopy can translate into additional single-use accessory utilization, while positive findings can increase demand for biopsy, resection, retrieval, injection, and closure products.
A third driver is the shift toward cold snare polypectomy and increasingly standardized lesion-management protocols. Cold snare resection has gained strong clinical acceptance for diminutive and small colorectal lesions because it avoids electrocautery-related thermal injury. This trend supports premium dedicated cold snares and encourages manufacturers to compete on wire configuration, tissue grip, shape retention, lesion capture, catheter stiffness, and physician ergonomics rather than price alone.
The fourth driver is continued expansion of advanced therapeutic endoscopy. Endoscopic mucosal resection, endoscopic submucosal dissection, peroral endoscopic myotomy, endoscopic suturing, transoral incisionless fundoplication, endoscopic full-thickness resection, and other organ-preserving techniques can replace or delay surgery in appropriately selected patients. These procedures use multiple high-value single-use instruments and can generate significantly greater device revenue per case than routine diagnostic endoscopy.
The fifth driver is ERCP and EUS procedural sophistication. Although ERCP volumes are much smaller than colonoscopy volumes, device intensity per case is substantially higher. Guidewires, cannulation devices, sphincterotomes, extraction balloons, stone baskets, dilation systems, cytology products, stents, drainage systems, and other consumables create attractive recurring revenue. EUS has expanded strongly over the past two decades, supporting demand for FNA and FNB needles and increasingly for interventional EUS accessories.
A sixth driver is infection prevention and the economics of reprocessing. The FDA has repeatedly encouraged transition away from older fixed-endcap duodenoscope designs toward technologies that facilitate or eliminate challenging reprocessing steps. This has encouraged disposable distal components, removable endcaps, and fully disposable endoscopic architectures. While not every reusable GI scope will be replaced by a single-use equivalent, contamination concerns have permanently changed purchasing criteria.
The seventh driver is outpatient procedure migration. ASCs and physician-owned endoscopy centers favor products that are predictable, easy to stock, quick to prepare, and compatible with lean staffing. Manufacturers that can demonstrate fewer device exchanges, simpler setup, lower reprocessing requirements, or faster turnover can justify a premium even when unit acquisition prices exceed reusable alternatives.
The eighth driver is hospital system consolidation. Large integrated delivery networks increasingly negotiate regional or national endoscopy contracts. Once a disposable product becomes standardized across a multi-hospital system, the resulting recurring revenue can be significant. Vendor breadth is therefore becoming a competitive advantage because health systems frequently prefer suppliers capable of bundling snares, clips, biopsy products, ERCP tools, EUS needles, retrieval devices, and other categories under unified pricing arrangements.
Innovation in Focus: How Manufacturers Are Raising the Bar?
Innovation in this market is moving toward procedural integration rather than simple product substitution. The strongest new products are designed to eliminate one procedural step, reduce an instrument exchange, improve visualization, increase tissue yield, facilitate difficult anatomy, or create more reliable closure.
Disposable gastrointestinal endoscopes represent the most visible innovation cycle. Fully single-use gastroscopes and selected colonoscopy platforms have progressed through U.S. regulatory pathways, creating an alternative to conventional reusable equipment. Their near-term opportunity is strongest in use cases where immediate availability, cross-contamination concerns, portability, emergency procedures, or limited reprocessing infrastructure outweigh the economics of high-volume reusable systems.
The technology is also advancing beyond basic disposable scopes. Manufacturers are improving working-channel size, image quality, suction, distal articulation, and compatibility with therapeutic accessories. The next competitive threshold will be whether disposable scopes can support increasingly therapeutic procedures without sacrificing physician handling characteristics.
Tissue acquisition is another important innovation area. Modern biopsy forceps compete on jaw capacity, sample integrity, flexibility, catheter characteristics, and procedural positioning. EUS fine-needle biopsy devices are evolving to improve core-tissue acquisition, histologic architecture, and diagnostic yield. These features matter commercially because better samples can reduce repeat procedures and improve downstream pathology workflow.
Resection technology is becoming increasingly specialized. Rather than using one generic snare for every lesion, U.S. endoscopy practices are adopting product configurations designed for diminutive polyps, flat lesions, large sessile lesions, EMR, and challenging right-colon anatomy. Cold snares, braided snares, rotating snares, and multi-stage products create room for clinical differentiation in what was historically viewed as a commoditized market.
Closure and hemostasis technologies are also expanding. Through-the-scope clips, over-the-scope systems, defect-closure platforms, hemostatic powders, injection devices, and combination therapies are becoming integral to complex endoscopic procedures. As more large lesions are treated endoscopically rather than surgically, demand increases for devices capable of controlling bleeding and closing larger mucosal or full-thickness defects.
Workflow innovation is an increasingly important competitive theme. Devices that combine two procedural functions can reduce exchanges and shorten case time. Injection-and-snare combinations, integrated retrieval products, enhanced distal attachments, and retraction devices for complex resection illustrate how single-use products can create economic value beyond their basic therapeutic function.
The market is simultaneously confronting sustainability concerns. Disposable products reduce reprocessing complexity but increase medical waste. U.S. health systems with formal environmental targets are beginning to scrutinize packaging, plastic volume, sterilization footprint, transportation requirements, recycling feasibility, and total life-cycle impact. Manufacturers that reduce packaging mass or create take-back and recycling models may gain procurement advantages without compromising the clinical benefits of single use.
Segmentation Insights
The U.S. Single-Use Gastroenterology Devices Market is segmented on the basis of product type, procedure type, clinical application, end user, and region.
By Product Type
Single-Use Gastrointestinal Endoscopes and Disposable Scope Components
Single-use gastrointestinal endoscopes are expected to represent the fastest-growing product category through 2035. The segment includes disposable gastroscopes, colonoscopes, selected enteroscopy platforms, and related single-use distal components or attachments. Adoption is moving first into environments where infection prevention, portability, procedure readiness, or limited reprocessing capacity create clear economic justification.
Disposable distal caps, valves, endoscope attachments, overtubes, and related components also represent an important subsegment because they allow health systems to retain reusable imaging platforms while replacing difficult-to-clean or contamination-sensitive components.
Tissue Acquisition and Biopsy Devices
Single-use biopsy forceps, cytology brushes, EUS aspiration needles, EUS biopsy needles, and specialty tissue-acquisition devices form one of the most recurring product groups. Demand is supported by colorectal screening, Barrett’s esophagus surveillance, gastric and esophageal lesion evaluation, pancreatic mass diagnosis, biliary abnormalities, and oncologic staging.
Premium growth is increasingly concentrated in devices that produce larger or more intact tissue cores. Diagnostic yield has direct economic consequences because inadequate specimens can lead to repeat endoscopy, additional pathology procedures, delayed treatment decisions, and patient dissatisfaction.
Polypectomy and Endoscopic Resection Devices
Polypectomy snares and advanced resection tools represent one of the largest revenue pools in the market. The U.S. colonoscopy base ensures high recurring consumption, while clinical movement toward dedicated cold snares is supporting product differentiation.
Advanced EMR and ESD products have higher revenue per procedure than routine snares. Injection needles, traction devices, cutting instruments, distal attachments, retrieval products, and closure devices may all be used during one complex lesion-resection case. This makes advanced resection one of the most strategically attractive areas for portfolio expansion.
Hemostasis and Closure Devices
Hemostatic clips, defect-closure systems, injection needles, thermal probes, hemostatic powders, and related accessories are increasingly important as therapeutic endoscopy expands.
The commercial opportunity extends beyond acute GI bleeding. Clips are also used prophylactically after selected resections, for defect closure, lesion marking, stent anchoring, and management of procedure-related perforation. Greater use of complex endoscopic resection will therefore expand closure-device utilization even if the underlying incidence of GI bleeding remains stable.
ERCP, EUS and Pancreaticobiliary Devices
This category includes guidewires, sphincterotomes, stone-extraction balloons, baskets, cytology devices, dilation catheters, access needles, drainage products, pancreatic and biliary accessories, and selected stent-delivery systems.
The segment carries high strategic importance because device spending per procedure is substantially above routine diagnostic endoscopy. Physician loyalty and procedural familiarity also create meaningful switching costs, allowing differentiated manufacturers to sustain premium positioning.
Dilation, Retrieval and Enteral-Access Devices
Dilation balloons, bougies, retrieval nets, graspers, foreign-body tools, PEG kits, gastropexy devices, enteral-access dilation systems, gastrostomy accessories, and other single-use products create a diversified recurring revenue pool.
Demand is supported by esophageal and intestinal strictures, dysphagia, foreign-body impaction, neurologic swallowing disorders, cancer-related nutrition requirements, and chronic enteral feeding. This category is more fragmented than polypectomy or ERCP, creating opportunities for specialist manufacturers.
By Procedure Type
Colonoscopy and Polypectomy
Colonoscopy represents the largest procedure-based market segment because of the scale of colorectal cancer screening, surveillance, diagnostic colonoscopy, and polyp removal. Approximately 13.8 million colonoscopies were estimated in the U.S. in 2019, giving manufacturers an enormous recurring consumable base.
The segment consumes biopsy forceps, cold and hot snares, retrieval nets, polyp traps, injection needles, clips, distal attachments, and marking agents. Growth through 2035 will depend less on basic diagnostic colonoscopy alone and more on screening expansion into the 45–49 age group, improved screening compliance, surveillance following polypectomy, and greater endoscopic treatment of larger lesions.
Upper GI Endoscopy
Upper endoscopy represents the second-largest procedure segment and supports demand for biopsy, dilation, hemostasis, foreign-body retrieval, Barrett’s surveillance, and therapeutic products.
U.S. upper endoscopy volumes were approximately 7.5 million procedures in 2019. GERD, dysphagia, upper GI bleeding, Barrett’s esophagus, gastric lesions, esophageal cancer evaluation, and post-surgical assessment provide a durable clinical base.
ERCP
ERCP is smaller in procedure count but substantially more device-intensive. Cannulation frequently requires multiple specialized disposable products, and difficult stone disease or malignant biliary obstruction can increase per-case device expenditure.
Future growth will be driven by improved biliary access, cholangioscopy-supported treatment, complex stone management, drainage procedures, and increasing use of specialty guidewires and stent technologies.
Endoscopic Ultrasound
EUS is among the most attractive growth procedures because it combines imaging with tissue acquisition and increasingly therapeutic intervention. Historical U.S. data show substantial expansion in upper EUS procedure volume.
Pancreatic cancer evaluation, subepithelial lesions, mediastinal assessment, biliary intervention, drainage, and tissue diagnosis support continued adoption of higher-value disposable needles and accessories.
Advanced Endoscopic Resection and Third-Space Procedures
EMR, ESD, POEM and other advanced endoluminal therapies remain lower-volume than conventional endoscopy but carry high device revenue per procedure. These procedures require specialized cutting, injection, traction, hemostasis, closure, and retrieval devices.
Adoption is concentrated in academic and high-volume referral centers today, but growing physician training and procedural standardization are expected to broaden the addressable market.
By Clinical Application
Colorectal Cancer Screening and Lesion Management
This is the dominant clinical application. In 2025, approximately 154,270 new colorectal cancer cases were expected in the U.S., while millions of additional patients undergo screening or surveillance for precancerous polyps.
The market opportunity begins before cancer diagnosis. Each screening colonoscopy creates potential demand for lesion visualization, biopsy, snare resection, specimen retrieval, marking, and hemostatic closure. Increasing screening among younger eligible adults creates an especially important long-term demand pool.
Gastrointestinal Bleeding
Acute and chronic GI bleeding supports demand for injection needles, clips, thermal probes, hemostatic powders, retrieval products, and diagnostic devices.
Hospitals place a premium on immediate device availability because GI bleeding can present as an urgent inpatient or emergency procedure. Single-use products fit this requirement because sterile inventory can be maintained without depending on reprocessing turnaround.
Pancreatic and Biliary Disease
Pancreaticobiliary disease generates a high-value device market across ERCP and EUS. Bile-duct stones, strictures, pancreatitis complications, pancreatic masses, cholangitis, biliary obstruction, and malignancy can require multiple disposable devices in one procedure.
Although volumes are lower than routine colonoscopy, revenue intensity and clinical complexity make this one of the most important premium segments.
Esophageal and Gastrointestinal Strictures
Dysphagia and benign or malignant strictures support recurring use of dilation balloons, guidewires, stents, injection products, and related accessories.
The aging population and high burden of reflux disease, esophageal cancer, post-surgical anatomy, radiation injury, and motility-related conditions support stable long-term demand.
Gastrointestinal Cancer Diagnosis and Staging
Beyond colorectal cancer, gastrointestinal endoscopy is central to the diagnosis of esophageal, gastric, pancreatic, biliary, and selected small-bowel malignancies. U.S. cancer projections for 2025 included more than 360,000 new cancers across the digestive system.
As cancer care becomes more tissue- and biomarker-dependent, the quality of endoscopically acquired specimens becomes increasingly important. This favors advanced FNB needles, larger-capacity biopsy forceps, and tissue-preservation technologies.
By End User
Hospitals and Integrated Health Systems
Hospitals represent the largest end-user segment because they manage complex ERCP, EUS, acute GI bleeding, advanced resection, high-risk patients, and inpatient gastrointestinal emergencies.
Large integrated systems increasingly use value-analysis committees to standardize disposable products. Manufacturers need clinical evidence, reliable supply, physician support, competitive system pricing, and product breadth to secure enterprise contracts.
Ambulatory Surgery Centers
ASCs represent the fastest-growing end-user opportunity for routine colonoscopy, upper endoscopy, biopsy, polypectomy, and selected therapeutic procedures.
The ASC economic model strongly favors predictable operating costs and rapid room turnover. Pre-sterile single-use devices can reduce handling steps and eliminate selected reprocessing requirements, making workflow efficiency a powerful commercial argument.
Physician-Owned Endoscopy Centers and Gastroenterology Practices
Independent endoscopy facilities remain strategically important because physician preference has a direct impact on product selection. These centers often perform very high annual colonoscopy and EGD volumes with small clinical teams.
Product reliability, simple ordering, distributor availability, procedure packs, low inventory complexity, and competitive case-level pricing are particularly important purchasing criteria.
Academic and Tertiary Referral Centers
Academic medical centers are disproportionately important for advanced therapeutic endoscopy. ESD, complex EMR, interventional EUS, third-space endoscopy, difficult ERCP, endoscopic suturing, and clinical trials tend to concentrate in these institutions.
Manufacturers frequently use leading academic centers as launch sites, training centers, evidence-generation partners, and reference accounts before expanding new products into community practice.
Pediatric and Specialty Gastroenterology Centers
Pediatric gastroenterology represents a smaller but strategically differentiated market. Smaller anatomy, sedation concerns, device diameter, and the desire to reduce procedure burden create opportunities for specialized single-use scopes and accessories.
Single-use transnasal endoscopy platforms are particularly relevant where clinicians aim to perform selected upper GI procedures without conventional sedation or operating-room resources.
Regional Insights: Where the Market is Growing Fastest
The U.S. Single-Use Gastroenterology Devices Market is geographically segmented into the South, West, Northeast and Midwest. This report estimates the South as the largest regional market in 2025, while the West is expected to record the fastest growth through 2035.
Regional demand differs according to population, colorectal screening participation, age distribution, GI specialist density, hospital infrastructure, ASC penetration, digestive disease burden, academic medical-center concentration, and adoption of advanced therapeutic endoscopy.
South
The South represents an estimated USD 1.05 billion market in 2025, or approximately 37% of U.S. revenue. Under the report forecast, the region could reach approximately USD 2.74 billion by 2035, implying growth above the national average.
The region includes Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma and Texas. Its leadership is driven by population scale, rapid demographic expansion, growing older-adult populations, large integrated health systems, expanding ASC networks, and significant unmet screening demand.
Texas is one of the most strategically important state markets. Its population exceeded 31.7 million in 2025, making it the second-largest state in the country. Houston, Dallas-Fort Worth, Austin, and San Antonio support major hospital systems, academic centers, cancer programs, and high-volume gastroenterology groups. Texas also recorded the largest absolute state population increase between 2024 and 2025, reinforcing the long-term procedure opportunity.
Florida is another dominant state market with approximately 23.5 million residents in 2025 and a large Medicare-age population. The state offers strong demand for colorectal screening, polypectomy, GI bleeding intervention, dilation, enteral access, pancreaticobiliary care, and therapeutic endoscopy. Large retirement populations create particularly durable demand for repeat surveillance procedures.
North Carolina, Georgia, South Carolina, Tennessee, and Virginia are high-growth markets. North Carolina exceeded 11.1 million residents in 2025 and was among the fastest-growing states nationally. Georgia exceeded 11.3 million. These states are adding hospital capacity, ambulatory facilities, and specialty physician infrastructure as populations migrate toward major metropolitan corridors.
Alabama, Mississippi, Louisiana, Kentucky, Arkansas, Oklahoma, and West Virginia represent smaller commercial markets but remain clinically important. Gastrointestinal cancer burden, chronic disease, rural access constraints, and uneven specialist distribution create demand for both centralized referral endoscopy and scalable disposable products that can be deployed across smaller facilities.
The South should remain the largest regional revenue pool through 2035 because it combines procedure-volume growth with expanding healthcare infrastructure. Manufacturers with strong ASC contracting, distributor reach, colorectal screening portfolios, and broad therapeutic offerings are particularly well positioned.
West
The West represented an estimated USD 0.68 billion in 2025 and is forecast to reach approximately USD 1.84 billion by 2035, making it the fastest-growing regional market under the report model.
The region includes California, Washington, Oregon, Nevada, Arizona, Idaho, Montana, Wyoming, Colorado, New Mexico, Utah, Alaska, and Hawaii.
California is the largest state opportunity in the West and the largest state in the country, with approximately 39.4 million residents in 2025. The state combines high procedural volume with major academic medical centers, large integrated delivery networks, prominent cancer programs, and an innovation-oriented healthcare environment. Advanced EMR, ESD, EUS, complex ERCP, AI-supported colonoscopy, and next-generation endoscopy platforms commonly achieve early adoption within California health systems.
California is also commercially important because large provider organizations can influence purchasing standards across multiple facilities. Manufacturers capable of integrating disposable accessories with broader endoscopy platforms can use these accounts as national reference sites.
Arizona, Nevada, Utah, Idaho, Colorado, and Washington are important growth states. Arizona exceeded 7.6 million residents in 2025 and continues to benefit from population migration and aging demographics. Washington exceeded 8 million residents, while Utah, Nevada, and Idaho remain among the faster-growing western states.
The West is particularly favorable for newer single-use technologies. Hospitals and specialty centers in the region frequently participate in clinical trials, pilot new procedural platforms, and evaluate digital or disposable care models. Sustainability scrutiny is also comparatively strong, meaning suppliers will increasingly need to demonstrate not only infection-prevention benefits but responsible packaging and waste-management strategies.
Oregon, New Mexico, Montana, Wyoming, Alaska, and Hawaii are smaller-volume markets. Geographic dispersion and limited specialist access in selected areas can nevertheless create a compelling value proposition for portable and immediately available disposable endoscopic technology.
Northeast
The Northeast accounted for an estimated USD 0.62 billion in 2025 and is projected to reach approximately USD 1.46 billion by 2035.
The region includes Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, New Jersey, and Pennsylvania. It is one of the most clinically sophisticated gastroenterology markets in the country and has a disproportionately high concentration of academic hospitals, fellowship programs, advanced endoscopists, cancer centers, and clinical research organizations.
New York is the region’s largest state market, with approximately 20 million residents in 2025. The state supports large procedure volumes across New York City, Long Island, Westchester, Buffalo, Rochester, Albany, and other major healthcare markets. Premium therapeutic endoscopy products can gain meaningful adoption because the state has strong concentrations of tertiary referral care.
Pennsylvania, with more than 13 million residents, has a large mix of academic medical centers, regional health systems, community hospitals, ASCs, and independent GI practices. New Jersey, with approximately 9.5 million residents, benefits from high physician density and proximity to major New York and Philadelphia referral networks.
Massachusetts is smaller by population but exceptionally influential in advanced endoscopy because of its concentration of teaching hospitals and medical-device research. Novel EUS, ESD, third-space, tissue-acquisition, and disposable endoscopy technologies often gain early clinician exposure through institutions in the Boston healthcare ecosystem.
Connecticut, Rhode Island, Maine, New Hampshire, and Vermont provide smaller but generally mature markets. Aging populations in Northern New England support screening and therapeutic demand, although lower population density can constrain procedure volumes.
The Northeast is expected to grow slightly below the South and West because many provider markets are already mature. However, it should remain disproportionately attractive for premium devices because of procedure complexity, specialist expertise, early clinical adoption, and strong evidence requirements.
Midwest
The Midwest represented an estimated USD 0.49 billion in 2025 and could reach approximately USD 1.11 billion by 2035.
The region includes Illinois, Indiana, Michigan, Ohio, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota.
Illinois, Ohio, Michigan, and Minnesota are the most strategically important states. Illinois had approximately 12.7 million residents in 2025, while Ohio approached 11.9 million and Michigan exceeded 10.1 million. Chicago, Cleveland, Columbus, Detroit, Minneapolis–St. Paul, and other metropolitan centers support sophisticated endoscopy programs and large referral networks.
Minnesota is commercially significant beyond its population because of its medical-device heritage and concentration of clinical expertise. Health systems in the state often emphasize evidence, quality metrics, and standardized procurement, creating opportunity for products that demonstrate measurable procedural efficiency.
Indiana, Wisconsin, Missouri, Iowa, Kansas, and Nebraska provide stable recurring demand from community hospitals, ASCs, and regional gastroenterology practices. Manufacturers often compete strongly on distributor availability, service, clinical education, and contracting rather than technology novelty alone.
North Dakota and South Dakota are smaller markets, but geographic dispersion and regional referral models can favor ready-to-use products and portable endoscopy solutions. Disposable technology may also reduce dependence on centralized reprocessing infrastructure in lower-volume facilities.
The Midwest is expected to grow more slowly than the South and West but should remain one of the most reliable markets for high-volume consumables. Companies that offer dependable supply, competitive case pricing, and broad portfolios can build durable relationships with regional health systems.
Key Market Players
The U.S. Single-Use Gastroenterology Devices Competitive Landscape is fragmented across broad multinational medtech companies, dedicated endoscopy suppliers, single-use scope innovators, therapeutic-endoscopy specialists, and enteral-access manufacturers.
Competition is increasingly portfolio-based. Major manufacturers seek to control more of the procedure by combining imaging platforms with snares, forceps, clips, needles, guidewires, dilation products, retrieval devices, ERCP accessories, EUS products, and other recurring consumables. Specialist companies can still gain share where they offer meaningful advantages in tissue acquisition, closure, advanced resection, infection prevention, or workflow efficiency.
Some of the key participants relevant to the U.S. market include Boston Scientific Corporation; Olympus Corporation of the Americas; Cook Medical; STERIS; CONMED Corporation; Medtronic; Ambu; EvoEndo; FUJIFILM Healthcare Americas Corporation; PENTAX Medical; Micro-Tech Endoscopy USA; Merit Medical Systems and Merit Endotek; ERBE USA; Laborie Medical Technologies and GI Supply; Creo Medical; Ovesco Endoscopy USA; Medi-Globe; Taewoong Medical USA; Avanos Medical; Applied Medical Technology; EnteraSense; EndoClot Plus; Limaca Medical; and Red Pine Medical.
Boston Scientific is one of the strongest broad-portfolio competitors, with products spanning single-use snares, biopsy forceps, dilation balloons, guidewires, EUS needles, retrieval products, clips, ERCP devices, and therapeutic-endoscopy tools.
Olympus combines one of the largest installed bases of reusable endoscopy equipment with a substantial single-use EndoTherapy portfolio. The company’s strategic advantage is the ability to influence both capital-platform selection and recurring procedural-device use.
Cook Medical has extensive depth in ERCP, hemostasis, tissue management, enteral access, dilation, stents, and pancreaticobiliary intervention. STERIS has a broad recurring-consumables portfolio covering snares, biopsy forceps, retrieval devices, injection needles, clips, enteroscopy products, procedure accessories, and infection-prevention products.
Ambu and EvoEndo are particularly important to the structural shift toward fully disposable gastrointestinal endoscopy. Their expansion illustrates how competition is moving beyond disposable accessories toward replacement of selected reusable scopes.
Micro-Tech, Ovesco, Creo Medical, Medi-Globe, Taewoong, Limaca, and other specialists compete by solving specific therapeutic or workflow problems. These companies can generate rapid adoption when a technology offers superior closure, tissue acquisition, resection, drainage, or device handling.
Over the forecast period, market share will be influenced by FDA clearances, procedure-specific evidence, integrated delivery network contracts, physician training, supply reliability, distributor reach, compatibility with major scope platforms, waste-reduction strategies, and the ability to quantify procedure-level economic value.
Recent Developments
Recent U.S. market developments show that the transition toward disposable endoscopic architectures is moving from concept toward commercial reality.
In February 2024, a single-use video gastroscope and single-use video colonoscope platform from Red Pine Medical received U.S. 510(k) clearance. The clearance demonstrated continued regulatory entry of disposable GI visualization technologies beyond early gastroscope-only applications.
In April 2024, Ambu received U.S. clearance for its aScope Gastro Large single-use gastroscope and associated visualization platform. The larger-channel configuration expanded the potential role of disposable gastroscopy toward procedures requiring greater suction and therapeutic accessory compatibility.
In 2025, Olympus received U.S. clearance for its D-201 Series disposable distal attachment. Disposable components that attach to reusable endoscopes represent an important intermediate model between fully reusable and fully disposable endoscopy because they can improve procedural functionality without requiring replacement of the installed capital platform.
Micro-Tech received U.S. clearance in June 2025 for a disposable distal cap, reinforcing competition in single-use scope attachments and accessory-driven procedural optimization.
EvoEndo continued expanding its single-use endoscopy platform through multiple U.S. clearances in 2025 and 2026. Its transnasal approach is especially relevant to pediatric and selected unsedated upper GI procedures because it has the potential to change where and how endoscopy is performed.
In February 2026, Olympus obtained U.S. clearance for its MAJ-2315 single-use distal cover used with duodenoscope systems. The continued development of disposable distal components aligns with the broader regulatory and clinical effort to reduce contamination risks associated with complex reusable duodenoscope components.
Therapeutic accessory innovation is advancing in parallel. Major suppliers have broadened dedicated cold-snare portfolios, advanced biopsy devices, retraction tools, integrated injection/resection systems, hemostatic clips, and complex defect-closure products. These technologies demonstrate that the market is evolving toward highly procedure-specific disposables rather than generic commodities.
The next development cycle is expected to focus on disposable scopes capable of supporting more therapeutic work, advanced EUS-guided intervention, large-defect closure, easier ESD traction, integrated devices that eliminate exchanges, and packaging designs that reduce the environmental burden associated with disposable care.
Conclusion
The U.S. Single-Use Gastroenterology Devices Market Size & Share is positioned to expand from approximately USD 2.84 billion in 2025 to USD 7.15 billion by 2035, representing a CAGR of 9.67% during 2026–2035.
The market is supported by an unusually strong combination of recurring procedure volume, colorectal screening demand, digestive disease burden, outpatient migration, therapeutic endoscopy growth, infection-prevention priorities, and hospital pressure to improve procedural efficiency.
The largest recurring opportunity will remain colonoscopy-associated consumables, including snares, biopsy forceps, retrieval products, injection needles, and clips. However, value growth will increasingly shift toward disposable GI endoscopes, advanced tissue acquisition, ERCP and EUS accessories, defect closure, EMR and ESD tools, and multifunctional devices designed to reduce procedural steps.
Hospital procurement will become more economically disciplined during the forecast period. Single use will not win merely because a product is disposable. Manufacturers will need to demonstrate why a device improves procedure reliability, reduces reprocessing requirements, increases room turnover, decreases contamination exposure, simplifies inventory, or reduces the probability of repeat intervention.
The South will remain the largest regional market because of population scale, demographic growth, large hospital networks, and expanding outpatient infrastructure. Texas and Florida will be especially important. The West is expected to record the fastest growth, led by California, Arizona, Washington, Utah, Nevada, and other expanding markets. The Northeast will remain the highest-acuity adoption environment for advanced endoscopy, while the Midwest will provide stable recurring demand from large health systems and community endoscopy networks.
For manufacturers, investors, distributors, hospital systems, and market entrants evaluating this industry, the central strategic issue is no longer simply whether gastroenterology will consume more disposable products. The more important questions are which procedures will produce the highest incremental device spend, where single-use economics can outperform established reusable workflows, which product categories can retain premium pricing, and which vendors can convert physician preference into enterprise-wide health-system adoption.
Companies that combine procedural innovation, reliable supply, clinical evidence, physician training, contracting flexibility, sustainability planning, and measurable workflow economics will be best positioned to capture the next decade of growth in the U.S. single-use gastroenterology devices industry.
TABLE OF CONTENT
1. U.S. Single-Use Gastroenterology Devices Market: Market Introduction & Context
1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Triangulation & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Market Inclusion and Exclusion Criteria
1.6.1. Single-Use GI Endoscopes
1.6.2. Disposable Endoscopic Accessories
1.6.3. Therapeutic Gastroenterology Consumables
1.6.4. ERCP and EUS Single-Use Devices
1.6.5. Exclusion of Reusable Endoscopes and Capital Imaging Systems
1.7. Stakeholder Analysis
1.7.1. Single-Use Gastroenterology Device Manufacturers
1.7.2. Endoscopy Platform and Accessory Manufacturers
1.7.3. Component, Sterilization and Contract Manufacturing Suppliers
1.7.4. Hospitals and Integrated Delivery Networks
1.7.5. Ambulatory Surgery Centers and Endoscopy Centers
1.7.6. Gastroenterology Practices and Specialty Clinics
1.7.7. Group Purchasing Organizations and Distributors
1.7.8. Gastroenterologists and Advanced Endoscopists
1.7.9. Payers, Regulators and Clinical Decision-Makers
What this section provides: This section defines the market boundary, study scope, inclusion and exclusion criteria, research methodology, sizing approach, assumptions, and stakeholder ecosystem used to measure and validate the U.S. Single-Use Gastroenterology Devices Market.
2. U.S. Single-Use Gastroenterology Devices Market: Executive Summary
2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size & Growth Trajectory, 2021–2035
2.8. High-Growth Opportunity Areas
2.8.1. Single-Use Gastrointestinal Endoscopes
2.8.2. Cold-Snare Polypectomy and Advanced Resection Devices
2.8.3. EUS Tissue Acquisition
2.8.4. ERCP Procedure Consumables
2.8.5. Endoscopic Hemostasis and Defect Closure
2.8.6. ASC-Oriented Disposable Procedure Solutions
What this section provides: This section gives decision-makers a concise view of market size, CAGR, historical performance, forecast direction, high-growth product categories, procedural demand pockets, competitive intensity, and priority investment opportunities.
3. U.S. Single-Use Gastroenterology Devices Market: Market Dynamics & Outlook
3.1. Drivers and Their Impact Analysis
3.1.1. High U.S. Colonoscopy and Upper GI Endoscopy Procedure Volumes
3.1.2. Expansion of Colorectal Cancer Screening from Age 45
3.1.3. Growing Adoption of Single-Use and Infection-Control-Oriented Devices
3.1.4. Rising Prevalence of Gastrointestinal and Pancreaticobiliary Disorders
3.1.5. Growth in Advanced Therapeutic Endoscopy
3.1.6. Increasing ERCP and EUS Procedure Sophistication
3.1.7. Shift of Gastrointestinal Procedures Toward Ambulatory Settings
3.1.8. Hospital Focus on Reprocessing Cost and Procedure-Room Turnover
3.2. Restraints and Their Impact Analysis
3.2.1. Higher Per-Procedure Acquisition Cost of Selected Single-Use Devices
3.2.2. Established Installed Base of Reusable Endoscopy Systems
3.2.3. Environmental and Medical-Waste Concerns
3.2.4. Hospital Value Analysis and Price Compression
3.2.5. Physician Preference and Device-Switching Resistance
3.2.6. Reimbursement Limitations for Premium Disposable Technology
3.3. Opportunities and Their Impact Analysis
3.3.1. Fully Disposable Gastroscope and Colonoscope Adoption
3.3.2. Advanced Endoscopic Resection and Third-Space Procedures
3.3.3. EUS-Guided Tissue Acquisition and Therapeutic EUS
3.3.4. Single-Use Duodenoscope Components and Infection Prevention
3.3.5. ASC and Physician-Owned Endoscopy Center Expansion
3.3.6. Procedure-Specific Disposable Kits and Bundled Consumables
3.3.7. Integrated Injection, Resection and Retrieval Technologies
3.3.8. Pediatric and Unsedated Transnasal Endoscopy
3.4. Challenges and Their Impact Analysis
3.4.1. Sustainability Versus Infection-Prevention Trade-Off
3.4.2. Clinical Equivalence Requirements
3.4.3. Supply-Chain and Sterilization Dependence
3.4.4. SKU Proliferation and Inventory Management
3.4.5. Competitive Bundling by Large Endoscopy Vendors
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Endoscope Reprocessing Cost and Utilization Analysis
3.8. Procedure-Level Disposable Device Consumption Analysis
3.9. Hospital and ASC Procurement Behavior Analysis
3.10. Gastroenterologist Preference and Product Standardization Analysis
What this section provides: This section explains the clinical, procedural, economic, infection-prevention, reimbursement, procurement, and sustainability forces shaping market demand and helps clients assess both upside potential and adoption barriers.
4. U.S. Single-Use Gastroenterology Devices Market: Market Environment & Industry Analysis
4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk from Reusable Devices
4.2.5. Competitive Rivalry
4.3. Average Selling Price Trend Analysis, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Raw Material, Sterilization and Packaging Ecosystem
4.6. Disposable Versus Reusable Device Economics
4.7. Infection Prevention and Reprocessing Landscape
4.8. Sustainability and Medical-Waste Impact Analysis
4.9. FDA Regulatory Framework Analysis
4.9.1. 510(k) Premarket Clearance Landscape
4.9.2. Device Classification Considerations
4.9.3. Single-Use Endoscope Regulatory Trends
4.9.4. Duodenoscope Safety and Disposable Component Requirements
4.10. CMS Reimbursement and Coverage Landscape
4.11. Ambulatory Surgery Center Reimbursement Dynamics
4.12. Import/Export Restrictions & Tariff Impact
4.13. Government and Public Health Screening Initiatives
4.14. Impact of Escalating Geopolitical and Supply-Chain Tensions
4.15. Hospital Value Analysis Committee Decision Framework
4.16. Group Purchasing Organization Influence
4.17. Environmental Procurement and Sustainable Purchasing Criteria
What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, pricing, sterilization, supply chain, sustainability, infection prevention, competitive substitution, and institutional purchasing dynamics.
5. U.S. Single-Use Gastroenterology Devices Market – By Product Type
5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
5.2. Single-Use Gastrointestinal Endoscopes & Disposable Scope Components
5.2.1. Single-Use Gastroscopes
5.2.2. Single-Use Colonoscopes
5.2.3. Single-Use Transnasal Endoscopes
5.2.4. Single-Use Duodenoscope Components
5.2.5. Disposable Distal Caps and Attachments
5.2.6. Single-Use Valves and Scope Accessories
5.3. Tissue Acquisition & Biopsy Devices
5.3.1. Disposable Biopsy Forceps
5.3.2. Cytology Brushes
5.3.3. EUS Fine Needle Aspiration Needles
5.3.4. EUS Fine Needle Biopsy Needles
5.3.5. Specialty Tissue Acquisition Devices
5.4. Polypectomy & Endoscopic Resection Devices
5.4.1. Cold Polypectomy Snares
5.4.2. Hot Polypectomy Snares
5.4.3. Rotatable and Specialty Snares
5.4.4. EMR Devices
5.4.5. ESD Devices
5.4.6. Injection Needles
5.4.7. Traction and Retraction Devices
5.4.8. Specimen Retrieval Devices
5.5. Hemostasis & Closure Devices
5.5.1. Through-the-Scope Clips
5.5.2. Over-the-Scope Closure Devices
5.5.3. Endoscopic Suturing and Defect Closure Accessories
5.5.4. Hemostatic Powders
5.5.5. Thermal Hemostasis Probes
5.5.6. Injection Hemostasis Devices
5.6. ERCP, EUS & Pancreaticobiliary Devices
5.6.1. Guidewires
5.6.2. Sphincterotomes
5.6.3. Stone Extraction Balloons
5.6.4. Stone Retrieval Baskets
5.6.5. Biliary and Pancreatic Dilation Devices
5.6.6. ERCP Cytology Devices
5.6.7. Drainage Accessories
5.6.8. Stent Delivery Accessories
5.7. Dilation, Retrieval & Enteral-Access Devices
5.7.1. Esophageal Dilation Balloons
5.7.2. Bougies and Dilators
5.7.3. Retrieval Nets
5.7.4. Graspers and Foreign-Body Retrieval Devices
5.7.5. PEG Kits
5.7.6. Gastropexy Devices
5.7.7. Enteral-Access Accessories
What this section provides: This section identifies the single-use GI device categories expected to generate the highest revenue, recurring procedure consumption, clinical differentiation, and growth through 2035.
6. U.S. Single-Use Gastroenterology Devices Market – By Procedure Type
6.1. Overview
6.1.1. Segment Share Analysis, By Procedure Type, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
6.2. Colonoscopy & Polypectomy
6.2.1. Screening Colonoscopy
6.2.2. Surveillance Colonoscopy
6.2.3. Diagnostic Colonoscopy
6.2.4. Cold Snare Polypectomy
6.2.5. Hot Snare Polypectomy
6.3. Upper Gastrointestinal Endoscopy
6.3.1. Diagnostic EGD
6.3.2. Upper GI Biopsy
6.3.3. Dilation Procedures
6.3.4. Upper GI Bleeding Intervention
6.3.5. Foreign-Body Retrieval
6.4. Endoscopic Retrograde Cholangiopancreatography
6.4.1. Biliary Cannulation
6.4.2. Sphincterotomy
6.4.3. Stone Extraction
6.4.4. Stricture Dilation
6.4.5. Biliary and Pancreatic Drainage
6.5. Endoscopic Ultrasound
6.5.1. Diagnostic EUS
6.5.2. EUS-FNA
6.5.3. EUS-FNB
6.5.4. Interventional EUS
6.5.5. EUS-Guided Drainage
6.6. Advanced Endoscopic Resection & Third-Space Endoscopy
6.6.1. Endoscopic Mucosal Resection
6.6.2. Endoscopic Submucosal Dissection
6.6.3. Peroral Endoscopic Myotomy
6.6.4. Endoscopic Full-Thickness Resection
6.6.5. Other Advanced Endoluminal Procedures
What this section provides: This section quantifies demand according to endoscopic procedure type and helps clients identify where procedure volumes, disposable-device intensity, clinical complexity, and per-case revenue are growing fastest.
7. U.S. Single-Use Gastroenterology Devices Market – By Clinical Application
7.1. Overview
7.1.1. Segment Share Analysis, By Clinical Application, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
7.2. Colorectal Cancer Screening & Colorectal Lesion Management
7.2.1. Screening and Surveillance
7.2.2. Polyp Detection and Tissue Sampling
7.2.3. Polypectomy
7.2.4. Advanced Colorectal Lesion Resection
7.2.5. Post-Resection Closure and Hemostasis
7.3. Gastrointestinal Bleeding
7.3.1. Upper GI Bleeding
7.3.2. Lower GI Bleeding
7.3.3. Variceal Bleeding
7.3.4. Post-Procedural Bleeding
7.3.5. Endoscopic Hemostasis and Closure
7.4. Pancreatic & Biliary Disease
7.4.1. Bile Duct Stones
7.4.2. Biliary Strictures
7.4.3. Pancreatic Lesions
7.4.4. Pancreatitis-Related Complications
7.4.5. Pancreaticobiliary Malignancy
7.4.6. Biliary and Pancreatic Drainage
7.5. Esophageal & Gastrointestinal Strictures
7.5.1. Benign Esophageal Strictures
7.5.2. Malignant Strictures
7.5.3. Dysphagia Management
7.5.4. Post-Surgical Strictures
7.5.5. Dilation and Stent-Related Procedures
7.6. Gastrointestinal Cancer Diagnosis, Staging & Therapy
7.6.1. Esophageal Cancer
7.6.2. Gastric Cancer
7.6.3. Colorectal Cancer
7.6.4. Pancreatic Cancer
7.6.5. Biliary Tract Cancer
7.6.6. Endoscopic Tissue Acquisition and Staging
What this section provides: This section helps clients understand device demand by clinical condition and prioritize applications with high procedure volumes, premium therapeutic-device utilization, screening relevance, cancer burden, and unmet clinical need.
8. U.S. Single-Use Gastroenterology Devices Market – By End User
8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
8.2. Hospitals & Integrated Health Systems
8.2.1. Academic Hospitals
8.2.2. Community Hospitals
8.2.3. Integrated Delivery Networks
8.2.4. Tertiary and Quaternary Referral Hospitals
8.3. Ambulatory Surgery Centers
8.3.1. Multispecialty ASCs
8.3.2. Gastroenterology-Focused ASCs
8.3.3. Health System-Owned ASCs
8.3.4. Physician-Owned ASCs
8.4. Physician-Owned Endoscopy Centers & Gastroenterology Practices
8.4.1. Independent Endoscopy Centers
8.4.2. Multisite Gastroenterology Groups
8.4.3. Private Gastroenterology Practices
8.5. Academic & Tertiary Referral Centers
8.5.1. Advanced Therapeutic Endoscopy Centers
8.5.2. Pancreaticobiliary Referral Centers
8.5.3. GI Cancer Centers
8.5.4. Clinical Trial and Training Centers
8.6. Pediatric & Specialty Gastroenterology Centers
8.6.1. Pediatric Hospitals
8.6.2. Pediatric GI Practices
8.6.3. Specialty Esophageal and Motility Centers
8.6.4. Transnasal Endoscopy Programs
What this section provides: This section explains which healthcare settings and customer groups drive single-use gastroenterology device purchasing and identifies differences in procedure mix, workflow priorities, price sensitivity, and adoption behavior.
9. U.S. Single-Use Gastroenterology Devices Market – By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
9.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
9.1.3. Regional GI Endoscopy Procedure Volume Analysis
9.1.4. Regional Hospital and ASC Infrastructure Analysis
9.1.5. Regional Colorectal Screening and Digestive Disease Burden
9.1.6. Regional Reimbursement and Procurement Dynamics
9.1.7. Regional Advanced Endoscopy Adoption Analysis
9.2. West Region
9.2.1. Regional Overview & Trends
9.2.2. West Region Key Manufacturers and Procurement Ecosystem
9.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.5. West Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.6. West Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.8. California
9.2.8.1. Overview
9.2.8.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.8.3. California Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.8.4. California Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.8.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.9. Washington
9.2.9.1. Overview
9.2.9.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.9.3. Washington Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.9.4. Washington Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.9.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.10. Arizona
9.2.10.1. Overview
9.2.10.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.10.3. Arizona Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.10.4. Arizona Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.10.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.11. Colorado
9.2.11.1. Overview
9.2.11.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.11.3. Colorado Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.11.4. Colorado Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.11.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.12. Oregon
9.2.12.1. Overview
9.2.12.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.12.3. Oregon Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.12.4. Oregon Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.12.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.13. Utah
9.2.13.1. Overview
9.2.13.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.13.3. Utah Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.13.4. Utah Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.13.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.14. Nevada
9.2.14.1. Overview
9.2.14.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.14.3. Nevada Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.14.4. Nevada Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.14.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.15. New Mexico
9.2.15.1. Overview
9.2.15.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.15.3. New Mexico Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.15.4. New Mexico Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.15.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.16. Idaho
9.2.16.1. Overview
9.2.16.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.16.3. Idaho Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.16.4. Idaho Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.16.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.17. Montana
9.2.17.1. Overview
9.2.17.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.17.3. Montana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.17.4. Montana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.17.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.18. Wyoming
9.2.18.1. Overview
9.2.18.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.18.3. Wyoming Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.18.4. Wyoming Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.18.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.19. Alaska
9.2.19.1. Overview
9.2.19.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.19.3. Alaska Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.19.4. Alaska Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.19.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.20. Hawaii
9.2.20.1. Overview
9.2.20.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.2.20.3. Hawaii Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.2.20.4. Hawaii Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.2.20.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3. Northeast Region
9.3.1. Regional Overview & Trends
9.3.2. Northeast Region Key Manufacturers and Procurement Ecosystem
9.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.5. Northeast Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.3.6. Northeast Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.8. New York
9.3.8.1. Overview
9.3.8.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.8.3. New York Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.3.8.4. New York Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.3.8.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.9. Massachusetts
9.3.9.1. Overview
9.3.9.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.9.3. Massachusetts Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.3.9.4. Massachusetts Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.3.9.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.10. New Jersey
9.3.10.1. Overview
9.3.10.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.10.3. New Jersey Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.3.10.4. New Jersey Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.3.10.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.11. Pennsylvania
9.3.11.1. Overview
9.3.11.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.11.3. Pennsylvania Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.3.11.4. Pennsylvania Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.3.11.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.12. Connecticut
9.3.12.1. Overview
9.3.12.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.12.3. Connecticut Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.3.12.4. Connecticut Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.3.12.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.13. Maine
9.3.13.1. Overview
9.3.13.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.13.3. Maine Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.3.13.4. Maine Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.3.13.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.14. Vermont
9.3.14.1. Overview
9.3.14.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.14.3. Vermont Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.3.14.4. Vermont Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.3.14.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.15. New Hampshire
9.3.15.1. Overview
9.3.15.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.15.3. New Hampshire Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.3.15.4. New Hampshire Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.3.15.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.16. Rhode Island
9.3.16.1. Overview
9.3.16.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.16.3. Rhode Island Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.3.16.4. Rhode Island Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.3.16.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.17. Delaware
9.3.17.1. Overview
9.3.17.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.3.17.3. Delaware Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.3.17.4. Delaware Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.3.17.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4. South Region
9.4.1. Regional Overview & Trends
9.4.2. South Region Key Manufacturers and Procurement Ecosystem
9.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.5. South Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.6. South Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.8. Texas
9.4.8.1. Overview
9.4.8.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.8.3. Texas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.8.4. Texas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.8.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.9. Florida
9.4.9.1. Overview
9.4.9.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.9.3. Florida Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.9.4. Florida Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.9.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.10. Georgia
9.4.10.1. Overview
9.4.10.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.10.3. Georgia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.10.4. Georgia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.10.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.11. North Carolina
9.4.11.1. Overview
9.4.11.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.11.3. North Carolina Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.11.4. North Carolina Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.11.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.12. Tennessee
9.4.12.1. Overview
9.4.12.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.12.3. Tennessee Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.12.4. Tennessee Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.12.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.13. South Carolina
9.4.13.1. Overview
9.4.13.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.13.3. South Carolina Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.13.4. South Carolina Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.13.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.14. Alabama
9.4.14.1. Overview
9.4.14.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.14.3. Alabama Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.14.4. Alabama Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.14.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.15. Mississippi
9.4.15.1. Overview
9.4.15.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.15.3. Mississippi Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.15.4. Mississippi Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.15.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.16. Louisiana
9.4.16.1. Overview
9.4.16.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.16.3. Louisiana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.16.4. Louisiana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.16.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.17. Arkansas
9.4.17.1. Overview
9.4.17.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.17.3. Arkansas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.17.4. Arkansas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.17.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.18. Kentucky
9.4.18.1. Overview
9.4.18.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.18.3. Kentucky Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.18.4. Kentucky Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.18.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.19. Oklahoma
9.4.19.1. Overview
9.4.19.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.19.3. Oklahoma Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.19.4. Oklahoma Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.19.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.20. Virginia
9.4.20.1. Overview
9.4.20.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.20.3. Virginia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.20.4. Virginia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.20.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.21. Maryland
9.4.21.1. Overview
9.4.21.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.21.3. Maryland Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.21.4. Maryland Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.21.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.22. West Virginia
9.4.22.1. Overview
9.4.22.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.4.22.3. West Virginia Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.4.22.4. West Virginia Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.4.22.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5. Midwest Region
9.5.1. Regional Overview & Trends
9.5.2. Midwest Region Key Manufacturers and Procurement Ecosystem
9.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.5. Midwest Region Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.5.6. Midwest Region Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.8. Illinois
9.5.8.1. Overview
9.5.8.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.8.3. Illinois Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.5.8.4. Illinois Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.5.8.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.9. Ohio
9.5.9.1. Overview
9.5.9.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.9.3. Ohio Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.5.9.4. Ohio Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.5.9.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.10. Michigan
9.5.10.1. Overview
9.5.10.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.10.3. Michigan Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.5.10.4. Michigan Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.5.10.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.11. Minnesota
9.5.11.1. Overview
9.5.11.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.11.3. Minnesota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.5.11.4. Minnesota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.5.11.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.12. Indiana
9.5.12.1. Overview
9.5.12.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.12.3. Indiana Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.5.12.4. Indiana Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.5.12.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.13. Wisconsin
9.5.13.1. Overview
9.5.13.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.13.3. Wisconsin Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.5.13.4. Wisconsin Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.5.13.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.14. Missouri
9.5.14.1. Overview
9.5.14.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.14.3. Missouri Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.5.14.4. Missouri Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.5.14.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.15. Iowa
9.5.15.1. Overview
9.5.15.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.15.3. Iowa Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.5.15.4. Iowa Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.5.15.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.16. Kansas
9.5.16.1. Overview
9.5.16.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.16.3. Kansas Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.5.16.4. Kansas Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.5.16.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.17. Nebraska
9.5.17.1. Overview
9.5.17.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.17.3. Nebraska Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.5.17.4. Nebraska Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.5.17.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.18. North Dakota
9.5.18.1. Overview
9.5.18.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.18.3. North Dakota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.5.18.4. North Dakota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.5.18.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.19. South Dakota
9.5.19.1. Overview
9.5.19.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
9.5.19.3. South Dakota Market Size and Forecast, By Procedure Type, 2021–2035 (US$ Billion)
9.5.19.4. South Dakota Market Size and Forecast, By Clinical Application, 2021–2035 (US$ Billion)
9.5.19.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed regional and state-level analysis covering all 50 states, helping clients identify priority geographies, GI procedure-volume hubs, colorectal-screening opportunities, advanced-endoscopy adoption hotspots, ASC concentration, and state-level commercial potential.
10. U.S. Single-Use Gastroenterology Devices Market: Competitive Landscape & Company Profiles
10.1. Market Share Analysis, 2025
10.2. Competitive Benchmarking
10.3. Company Positioning Matrix
10.3.1. Leaders
10.3.2. Challengers
10.3.3. Innovators
10.3.4. Emerging Players
10.4. Product Portfolio Benchmarking
10.5. Disposable Endoscope Competitive Analysis
10.6. Therapeutic Endoscopy Accessory Competitive Analysis
10.7. Mergers, Acquisitions, Partnerships & Distribution Agreements
10.8. FDA Clearance and Product Launch Benchmarking
10.9. U.S. Commercial Strategy Comparison
10.10. Company Profiles
10.10.1. Boston Scientific Corporation
10.10.2. Olympus Corporation of the Americas
10.10.3. Cook Medical
10.10.4. STERIS
10.10.5. CONMED Corporation
10.10.6. Medtronic
10.10.7. Ambu A/S
10.10.8. EvoEndo
10.10.9. FUJIFILM Healthcare Americas Corporation
10.10.10. PENTAX Medical
10.10.11. Micro-Tech Endoscopy USA
10.10.12. Merit Medical Systems / Merit Endotek
10.10.13. ERBE USA
10.10.14. Laborie Medical Technologies / GI Supply
10.10.15. Creo Medical
10.10.16. Ovesco Endoscopy USA
10.10.17. Medi-Globe
10.10.18. Taewoong Medical USA
10.10.19. Avanos Medical
10.10.20. Applied Medical Technology
10.10.21. EndoClot Plus
10.10.22. Limaca Medical
10.10.23. Red Pine Medical
10.10.24. EnteraSense
Note: Each company profile will include company overview, U.S. single-use gastroenterology device portfolio, product positioning, target procedures, commercial strategy, FDA/regulatory developments, partnerships, innovation pipeline, competitive strengths, and recent developments.
What this section provides: This section gives clients competitor benchmarking, market-share visibility, product and procedure positioning, innovation direction, regulatory momentum, and strategic intelligence on major and emerging participants in the U.S. single-use gastroenterology device ecosystem.
11. U.S. Single-Use Gastroenterology Devices Market: Future Market Outlook, 2026–2035
11.1. Scenario Analysis
11.1.1. Optimistic Scenario
11.1.2. Realistic Scenario
11.1.3. Pessimistic Scenario
11.2. Disruptive Technologies Impact
11.2.1. Fully Disposable GI Endoscopes
11.2.2. Next-Generation Single-Use Colonoscopy Platforms
11.2.3. Single-Use Therapeutic Gastroscopes
11.2.4. Advanced EUS Tissue Acquisition
11.2.5. Integrated Endoscopic Resection Devices
11.2.6. Next-Generation Defect Closure Systems
11.2.7. Therapeutic EUS and Endoscopic Drainage
11.2.8. Third-Space Endoscopy
11.2.9. AI-Enabled Endoscopy and Its Impact on Disposable Device Utilization
11.3. Disposable Versus Reusable Market Transition Outlook
11.4. Sustainability and Circular-Economy Outlook
11.5. Emerging Business Trends
11.6. Procedure Migration to ASCs and Office-Based Settings
11.7. Business Opportunities for Startups and Existing Players
11.8. Investment Prioritization Matrix
11.9. Product Category Attractiveness Matrix
11.10. White-Space Opportunity Analysis
What this section provides: This section prepares clients for future shifts in device architecture, therapeutic endoscopy, care-site migration, sustainability requirements, competitive structure, investment priorities, and potential adoption scenarios through 2035.
12. U.S. Single-Use Gastroenterology Devices Market: Strategic Recommendations
12.1. Recommendations for Single-Use Device Manufacturers
12.2. Recommendations for Endoscopy Platform Companies
12.3. Recommendations for Hospitals and Integrated Health Systems
12.4. Recommendations for Ambulatory Surgery Centers
12.5. Recommendations for Gastroenterology Practices and Endoscopy Centers
12.6. Recommendations for Investors and Private Equity Firms
12.7. Recommendations for Distributors and Channel Partners
12.8. Recommendations for New Entrants and Startups
12.9. U.S. Market Entry Strategy Considerations
12.10. Product Positioning and Portfolio Expansion Guidance
12.11. Physician Adoption and KOL Development Strategy
12.12. IDN and GPO Contracting Strategy
12.13. Evidence Generation and Health-Economic Positioning
12.14. Sustainability and Waste-Reduction Strategy
12.15. Acquisition and Partnership Opportunity Framework
What this section provides: This section converts market intelligence into actionable strategy for market entry, portfolio expansion, product positioning, hospital and ASC contracting, physician adoption, investment planning, evidence generation, and competitive differentiation.
13. U.S. Single-Use Gastroenterology Devices Market: Disclaimer
13.1. Scope Limitation
13.2. Data Use Limitation
13.3. Market Sizing Limitation
13.4. Forecasting Limitation
13.5. State-Level Estimate Limitation
13.6. Legal Disclaimer
13.7. Third-Party Data Disclaimer
13.8. Regulatory and Reimbursement Disclaimer
What this section provides: This section clarifies the report’s market boundaries, data-use limitations, state-level estimation methodology, forecasting assumptions, regulatory considerations, and legal terms.
List of Tables
TABLE 1: List of Data Sources
TABLE 2: U.S. Single-Use Gastroenterology Devices Market: Market Definition and Scope
TABLE 3: U.S. Single-Use Gastroenterology Devices Market: Research Methodology Framework
TABLE 4: U.S. Single-Use Gastroenterology Devices Market: Key Assumptions
TABLE 5: U.S. Single-Use Gastroenterology Devices Market: Market Inclusion and Exclusion Criteria
TABLE 6: U.S. Single-Use Gastroenterology Devices Market: Market Ecosystem Overview
TABLE 7: U.S. Single-Use Gastroenterology Devices Market: Stakeholder Analysis
TABLE 8: U.S. Single-Use Gastroenterology Devices Market: Market Sizing and Validation Framework
TABLE 9: U.S. Single-Use Gastroenterology Devices Market: Executive Summary Snapshot, 2025
TABLE 10: U.S. Single-Use Gastroenterology Devices Market: Analyst Viewpoint Summary
TABLE 11: U.S. Single-Use Gastroenterology Devices Market: Market Attractiveness Index
TABLE 12: U.S. Single-Use Gastroenterology Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 13: U.S. Single-Use Gastroenterology Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 14: U.S. Single-Use Gastroenterology Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 15: U.S. Single-Use Gastroenterology Devices Market: High-Growth Opportunity Areas
TABLE 16: U.S. Single-Use Gastroenterology Devices Market: Drivers; Impact Analysis
TABLE 17: U.S. Single-Use Gastroenterology Devices Market: Restraints; Impact Analysis
TABLE 18: U.S. Single-Use Gastroenterology Devices Market: Opportunities; Impact Analysis
TABLE 19: U.S. Single-Use Gastroenterology Devices Market: Challenges; Impact Analysis
TABLE 20: U.S. Single-Use Gastroenterology Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 21: U.S. Single-Use Gastroenterology Devices Market: Clinical Workflow Economics Matrix
TABLE 22: U.S. Single-Use Gastroenterology Devices Market: Endoscope Reprocessing Cost and Utilization Analysis
TABLE 23: U.S. Single-Use Gastroenterology Devices Market: Procedure-Level Disposable Device Consumption Analysis
TABLE 24: U.S. Single-Use Gastroenterology Devices Market: Hospital and ASC Procurement Behavior Matrix
TABLE 25: U.S. Single-Use Gastroenterology Devices Market: Gastroenterologist Preference and Product Standardization Analysis
TABLE 26: U.S. Single-Use Gastroenterology Devices Market: PESTEL Analysis
TABLE 27: U.S. Single-Use Gastroenterology Devices Market: Porter’s Five Forces Analysis
TABLE 28: U.S. Single-Use Gastroenterology Devices Market: Average Selling Price Trend Analysis, 2025–2035
TABLE 29: U.S. Single-Use Gastroenterology Devices Market: Value Chain Analysis
TABLE 30: U.S. Single-Use Gastroenterology Devices Market: Supply Chain Analysis
TABLE 31: U.S. Single-Use Gastroenterology Devices Market: Raw Material, Sterilization and Packaging Ecosystem
TABLE 32: U.S. Single-Use Gastroenterology Devices Market: Disposable Versus Reusable Device Economics
TABLE 33: U.S. Single-Use Gastroenterology Devices Market: Infection Prevention and Reprocessing Landscape
TABLE 34: U.S. Single-Use Gastroenterology Devices Market: Sustainability and Medical-Waste Impact Analysis
TABLE 35: U.S. Single-Use Gastroenterology Devices Market: FDA Regulatory Framework Analysis
TABLE 36: U.S. Single-Use Gastroenterology Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 37: U.S. Single-Use Gastroenterology Devices Market: ASC Reimbursement Dynamics
TABLE 38: U.S. Single-Use Gastroenterology Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 39: U.S. Single-Use Gastroenterology Devices Market: Government and Public Health Screening Initiatives
TABLE 40: U.S. Single-Use Gastroenterology Devices Market: Geopolitical and Supply-Chain Risk Analysis
TABLE 41: U.S. Single-Use Gastroenterology Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 42: U.S. Single-Use Gastroenterology Devices Market: GPO Influence and Sustainable Procurement Criteria
TABLE 43: U.S. Single-Use Gastroenterology Devices Market: Product Type Snapshot, 2025
TABLE 44: Segment Dashboard; Definition and Scope, by Product Type
TABLE 45: U.S. Single-Use Gastroenterology Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 46: U.S. Single-Use Gastroenterology Devices Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 47: Single-Use Gastrointestinal Endoscopes & Disposable Scope Components Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: Tissue Acquisition & Biopsy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: Polypectomy & Endoscopic Resection Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: Hemostasis & Closure Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: ERCP, EUS & Pancreaticobiliary Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: Dilation, Retrieval & Enteral-Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Single-Use Gastroenterology Devices Market: Procedure Type Snapshot, 2025
TABLE 54: Segment Dashboard; Definition and Scope, by Procedure Type
TABLE 55: U.S. Single-Use Gastroenterology Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 56: U.S. Single-Use Gastroenterology Devices Market: Segment Share Analysis, by Procedure Type, 2025 & 2035 (%)
TABLE 57: Colonoscopy & Polypectomy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: Upper Gastrointestinal Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: Endoscopic Retrograde Cholangiopancreatography Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: Endoscopic Ultrasound Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: Advanced Endoscopic Resection & Third-Space Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Single-Use Gastroenterology Devices Market: Clinical Application Snapshot, 2025
TABLE 63: Segment Dashboard; Definition and Scope, by Clinical Application
TABLE 64: U.S. Single-Use Gastroenterology Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 65: U.S. Single-Use Gastroenterology Devices Market: Segment Share Analysis, by Clinical Application, 2025 & 2035 (%)
TABLE 66: Colorectal Cancer Screening & Colorectal Lesion Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: Gastrointestinal Bleeding Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: Pancreatic & Biliary Disease Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: Esophageal & Gastrointestinal Strictures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: Gastrointestinal Cancer Diagnosis, Staging & Therapy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Single-Use Gastroenterology Devices Market: End User Snapshot, 2025
TABLE 72: Segment Dashboard; Definition and Scope, by End User
TABLE 73: U.S. Single-Use Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 74: U.S. Single-Use Gastroenterology Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 75: Hospitals & Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: Physician-Owned Endoscopy Centers & Gastroenterology Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: Academic & Tertiary Referral Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: Pediatric & Specialty Gastroenterology Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Single-Use Gastroenterology Devices Market: Regional Snapshot, 2025
TABLE 81: Segment Dashboard; Definition and Scope, by Geography
TABLE 82: U.S. Single-Use Gastroenterology Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 83: U.S. Single-Use Gastroenterology Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 84: U.S. Single-Use Gastroenterology Devices Market: Regional GI Endoscopy Procedure Volume and Infrastructure Analysis
TABLE 85: U.S. Single-Use Gastroenterology Devices Market: Regional Reimbursement and Procurement Dynamics
TABLE 86: West Region U.S. Single-Use Gastroenterology Devices Market: Regional Overview and Trends
TABLE 87: West Region U.S. Single-Use Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 88: West Region U.S. Single-Use Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Single-Use Gastroenterology Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 90: West Region U.S. Single-Use Gastroenterology Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 91: West Region U.S. Single-Use Gastroenterology Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 92: West Region U.S. Single-Use Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 93: California Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Washington Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: Arizona Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: Colorado Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Oregon Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Utah Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Nevada Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: New Mexico Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Idaho Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Montana Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Wyoming Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Alaska Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Hawaii Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Northeast Region U.S. Single-Use Gastroenterology Devices Market: Regional Overview and Trends
TABLE 107: Northeast Region U.S. Single-Use Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 108: Northeast Region U.S. Single-Use Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 109: Northeast Region U.S. Single-Use Gastroenterology Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 110: Northeast Region U.S. Single-Use Gastroenterology Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 111: Northeast Region U.S. Single-Use Gastroenterology Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 112: Northeast Region U.S. Single-Use Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 113: New York Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Massachusetts Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: New Jersey Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Pennsylvania Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Connecticut Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Maine Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Vermont Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: New Hampshire Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: Rhode Island Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: Delaware Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: South Region U.S. Single-Use Gastroenterology Devices Market: Regional Overview and Trends
TABLE 124: South Region U.S. Single-Use Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 125: South Region U.S. Single-Use Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 126: South Region U.S. Single-Use Gastroenterology Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 127: South Region U.S. Single-Use Gastroenterology Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 128: South Region U.S. Single-Use Gastroenterology Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 129: South Region U.S. Single-Use Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 130: Texas Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Florida Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Georgia Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: North Carolina Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: Tennessee Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: South Carolina Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Alabama Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Mississippi Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Louisiana Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Arkansas Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Kentucky Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Oklahoma Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Virginia Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Maryland Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: West Virginia Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Midwest Region U.S. Single-Use Gastroenterology Devices Market: Regional Overview and Trends
TABLE 146: Midwest Region U.S. Single-Use Gastroenterology Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 147: Midwest Region U.S. Single-Use Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 148: Midwest Region U.S. Single-Use Gastroenterology Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 149: Midwest Region U.S. Single-Use Gastroenterology Devices Market, by Procedure Type, 2021–2035 (US$ Billion)
TABLE 150: Midwest Region U.S. Single-Use Gastroenterology Devices Market, by Clinical Application, 2021–2035 (US$ Billion)
TABLE 151: Midwest Region U.S. Single-Use Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 152: Illinois Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Ohio Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Michigan Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Minnesota Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: Indiana Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: Wisconsin Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 158: Missouri Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 159: Iowa Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 160: Kansas Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 161: Nebraska Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: North Dakota Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: South Dakota Single-Use Gastroenterology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: U.S. Single-Use Gastroenterology Devices Market: Competitive Landscape Snapshot, 2025
TABLE 165: U.S. Single-Use Gastroenterology Devices Market: Key Company Market Share Analysis, 2025
TABLE 166: U.S. Single-Use Gastroenterology Devices Market: Company Positioning Matrix
TABLE 167: U.S. Single-Use Gastroenterology Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 168: U.S. Single-Use Gastroenterology Devices Market: Disposable Endoscope Competitive Benchmarking
TABLE 169: U.S. Single-Use Gastroenterology Devices Market: Therapeutic Endoscopy Accessory Competitive Benchmarking
TABLE 170: U.S. Single-Use Gastroenterology Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 171: U.S. Single-Use Gastroenterology Devices Market: FDA Clearance and U.S. Commercial Strategy Benchmarking
TABLE 172: Boston Scientific Corporation: Company Profile
TABLE 173: Olympus Corporation of the Americas: Company Profile
TABLE 174: Cook Medical: Company Profile
TABLE 175: STERIS: Company Profile
TABLE 176: CONMED Corporation: Company Profile
TABLE 177: Medtronic: Company Profile
TABLE 178: Ambu A/S: Company Profile
TABLE 179: EvoEndo: Company Profile
TABLE 180: FUJIFILM Healthcare Americas Corporation: Company Profile
TABLE 181: PENTAX Medical: Company Profile
TABLE 182: Micro-Tech Endoscopy USA: Company Profile
TABLE 183: Merit Medical Systems / Merit Endotek: Company Profile
TABLE 184: ERBE USA: Company Profile
TABLE 185: Laborie Medical Technologies / GI Supply: Company Profile
TABLE 186: Creo Medical: Company Profile
TABLE 187: Ovesco Endoscopy USA: Company Profile
TABLE 188: Medi-Globe: Company Profile
TABLE 189: Taewoong Medical USA: Company Profile
TABLE 190: Avanos Medical: Company Profile
TABLE 191: Applied Medical Technology: Company Profile
TABLE 192: EndoClot Plus: Company Profile
TABLE 193: Limaca Medical: Company Profile
TABLE 194: Red Pine Medical: Company Profile
TABLE 195: EnteraSense: Company Profile
TABLE 196: U.S. Single-Use Gastroenterology Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 197: U.S. Single-Use Gastroenterology Devices Market: Disruptive Technologies Impact Matrix
TABLE 198: U.S. Single-Use Gastroenterology Devices Market: Disposable Versus Reusable Transition Outlook
TABLE 199: U.S. Single-Use Gastroenterology Devices Market: Sustainability and Circular-Economy Outlook
TABLE 200: U.S. Single-Use Gastroenterology Devices Market: Emerging Business Trends
TABLE 201: U.S. Single-Use Gastroenterology Devices Market: ASC Procedure Migration Outlook
TABLE 202: U.S. Single-Use Gastroenterology Devices Market: Business Opportunities for Startups and Existing Players
TABLE 203: U.S. Single-Use Gastroenterology Devices Market: Investment Prioritization Matrix
TABLE 204: U.S. Single-Use Gastroenterology Devices Market: Product Category Attractiveness Matrix
TABLE 205: U.S. Single-Use Gastroenterology Devices Market: White-Space Opportunity Analysis
TABLE 206: U.S. Single-Use Gastroenterology Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 207: U.S. Single-Use Gastroenterology Devices Market: Strategic Recommendations for Endoscopy Platform Companies
TABLE 208: U.S. Single-Use Gastroenterology Devices Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 209: U.S. Single-Use Gastroenterology Devices Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 210: U.S. Single-Use Gastroenterology Devices Market: Strategic Recommendations for Gastroenterology Practices
TABLE 211: U.S. Single-Use Gastroenterology Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 212: U.S. Single-Use Gastroenterology Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 213: U.S. Single-Use Gastroenterology Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 214: U.S. Single-Use Gastroenterology Devices Market: U.S. Market Entry and Go-to-Market Strategy
TABLE 215: U.S. Single-Use Gastroenterology Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 216: U.S. Single-Use Gastroenterology Devices Market: Physician Adoption and KOL Development Strategy
TABLE 217: U.S. Single-Use Gastroenterology Devices Market: IDN and GPO Contracting Strategy
TABLE 218: U.S. Single-Use Gastroenterology Devices Market: Evidence Generation and Health-Economic Positioning
TABLE 219: U.S. Single-Use Gastroenterology Devices Market: Sustainability and Waste-Reduction Strategy
TABLE 220: U.S. Single-Use Gastroenterology Devices Market: Scope Limitation
TABLE 221: U.S. Single-Use Gastroenterology Devices Market: Data Use Limitation
TABLE 222: U.S. Single-Use Gastroenterology Devices Market: Market Sizing Limitation
TABLE 223: U.S. Single-Use Gastroenterology Devices Market: Forecasting Limitation
TABLE 224: U.S. Single-Use Gastroenterology Devices Market: State-Level Estimate Limitation
TABLE 225: U.S. Single-Use Gastroenterology Devices Market: Legal Disclaimer
TABLE 226: U.S. Single-Use Gastroenterology Devices Market: Third-Party Data Disclaimer
TABLE 227: U.S. Single-Use Gastroenterology Devices Market: Regulatory and Reimbursement Disclaimer
List of Figures
FIGURE 1: U.S. Single-Use Gastroenterology Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem
FIGURE 4: Stakeholder Ecosystem
FIGURE 5: Market Sizing and Validation Framework
FIGURE 6: U.S. Single-Use Gastroenterology Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 7: U.S. Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 8: U.S. Single-Use Gastroenterology Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 9: Market Attractiveness Analysis
FIGURE 10: U.S. Single-Use Gastroenterology Devices Market Dynamics
FIGURE 11: Drivers and Restraints Impact Matrix
FIGURE 12: Innovation & Patent Landscape, 2021–2025
FIGURE 13: Clinical Workflow Economics Framework
FIGURE 14: Endoscope Reprocessing Versus Single-Use Workflow Economics
FIGURE 15: Hospital and ASC Procurement Decision Framework
FIGURE 16: PESTEL Analysis
FIGURE 17: Porter’s Five Forces Analysis
FIGURE 18: Value Chain Analysis
FIGURE 19: Supply Chain Analysis
FIGURE 20: Disposable Versus Reusable Device Economics Framework
FIGURE 21: Infection Prevention and Reprocessing Landscape
FIGURE 22: FDA Regulatory and Reimbursement Landscape
FIGURE 23: Sustainability and Medical-Waste Impact Framework
FIGURE 24: Hospital Value Analysis Committee Decision Framework
FIGURE 25: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 26: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Single-Use Gastrointestinal Endoscopes & Disposable Scope Components Market Size Forecast, 2021–2035
FIGURE 28: Tissue Acquisition & Biopsy Devices Market Size Forecast, 2021–2035
FIGURE 29: Polypectomy & Endoscopic Resection Devices Market Size Forecast, 2021–2035
FIGURE 30: Hemostasis & Closure Devices Market Size Forecast, 2021–2035
FIGURE 31: ERCP, EUS & Pancreaticobiliary Devices Market Size Forecast, 2021–2035
FIGURE 32: Dilation, Retrieval & Enteral-Access Devices Market Size Forecast, 2021–2035
FIGURE 33: Procedure Type Segment Market Share Analysis, 2025 & 2035
FIGURE 34: Procedure Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Colonoscopy & Polypectomy Market Size Forecast, 2021–2035
FIGURE 36: Upper Gastrointestinal Endoscopy Market Size Forecast, 2021–2035
FIGURE 37: ERCP Market Size Forecast, 2021–2035
FIGURE 38: Endoscopic Ultrasound Market Size Forecast, 2021–2035
FIGURE 39: Advanced Endoscopic Resection & Third-Space Endoscopy Market Size Forecast, 2021–2035
FIGURE 40: Clinical Application Segment Market Share Analysis, 2025 & 2035
FIGURE 41: Clinical Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Colorectal Cancer Screening & Lesion Management Market Size Forecast, 2021–2035
FIGURE 43: Gastrointestinal Bleeding Market Size Forecast, 2021–2035
FIGURE 44: Pancreatic & Biliary Disease Market Size Forecast, 2021–2035
FIGURE 45: Esophageal & Gastrointestinal Strictures Market Size Forecast, 2021–2035
FIGURE 46: Gastrointestinal Cancer Diagnosis, Staging & Therapy Market Size Forecast, 2021–2035
FIGURE 47: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 48: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Hospitals & Integrated Health Systems Market Size Forecast, 2021–2035
FIGURE 50: Ambulatory Surgery Centers Market Size Forecast, 2021–2035
FIGURE 51: Physician-Owned Endoscopy Centers & Gastroenterology Practices Market Size Forecast, 2021–2035
FIGURE 52: Academic & Tertiary Referral Centers Market Size Forecast, 2021–2035
FIGURE 53: Pediatric & Specialty Gastroenterology Centers Market Size Forecast, 2021–2035
FIGURE 54: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 55: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Regional GI Endoscopy Procedure Volume and Infrastructure Comparison
FIGURE 57: West Region U.S. Single-Use Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 58: West Region Market Share Analysis by State, 2025
FIGURE 59: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: California Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Washington Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Arizona Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Colorado Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Oregon Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Utah Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Nevada Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: New Mexico Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Idaho Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Montana Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Wyoming Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Alaska Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Hawaii Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Northeast Region U.S. Single-Use Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 74: Northeast Region Market Share Analysis by State, 2025
FIGURE 75: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: New York Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Massachusetts Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New Jersey Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Pennsylvania Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Connecticut Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Maine Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Vermont Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: New Hampshire Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Rhode Island Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Delaware Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: South Region U.S. Single-Use Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 87: South Region Market Share Analysis by State, 2025
FIGURE 88: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Texas Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Florida Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Georgia Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: North Carolina Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Tennessee Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: South Carolina Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Alabama Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Mississippi Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Louisiana Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Arkansas Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Kentucky Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Oklahoma Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Virginia Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Maryland Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: West Virginia Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Midwest Region U.S. Single-Use Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 105: Midwest Region Market Share Analysis by State, 2025
FIGURE 106: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Illinois Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Ohio Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Michigan Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Minnesota Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Indiana Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Wisconsin Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Missouri Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Iowa Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Kansas Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Nebraska Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: North Dakota Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: South Dakota Single-Use Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 120: Company Positioning Matrix
FIGURE 121: Key Player Product Portfolio Benchmarking
FIGURE 122: Disposable Endoscope Competitive Landscape
FIGURE 123: Therapeutic Endoscopy Accessory Competitive Landscape
FIGURE 124: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 125: FDA Clearance and Commercialization Roadmap
FIGURE 126: Future Market Scenario Analysis, 2026–2035
FIGURE 127: Disruptive Technologies Impact Matrix
FIGURE 128: Single-Use GI Endoscopy Innovation Roadmap
FIGURE 129: Disposable Versus Reusable Market Transition Roadmap
FIGURE 130: Advanced Therapeutic Endoscopy Opportunity Map
FIGURE 131: ASC Procedure Migration Roadmap
FIGURE 132: Sustainability and Circular-Economy Outlook
FIGURE 133: Investment Prioritization Matrix
FIGURE 134: White-Space Opportunity Map
FIGURE 135: Strategic Growth Roadmap for U.S. Single-Use Gastroenterology Device Companies
FIGURE 136: U.S. Market Entry and Go-to-Market Strategy Framework
FIGURE 137: Product Positioning and Portfolio Expansion Framework
FIGURE 138: IDN and GPO Contracting Framework
FIGURE 139: Physician Adoption and KOL Development Framework
FIGURE 140: Evidence Generation and Health-Economic Positioning Framework
FIGURE 141: Report Scope, Market Boundaries and Disclaimer Framework